Integrated CDMO VxP offers both small molecule and biologics development and manufacturing, including live virus vaccines and preclinical/toxicology support, presenting a one-stop solution for clients seeking end-to-end development and manufacturing.

Global biologics footprint Operates across the United States, Europe, India, and East Asia with FDA-audited facilities and a history of collaboration with global pharma and virtual companies, enabling scalable regional or global outsourcing strategies.

Bio-defense credentials Facilities are part of the US Bio-Defense Grid, providing global countermeasures and public health products, which can be leveraged to win contracts tied to national security, outbreak preparedness, and regulatory-compliant safeguarding.

Regulatory readiness Long track record of FDA interactions and full regulatory support across programs, suggesting a strong fit for clients needing rigorous regulatory planning, submissions, and quality/compliance expertise.

SM & biologics ramp Small molecule and biologics capabilities, plus preclinical and analytical support, open up cross-domain opportunities in programs transitioning from discovery to clinic, as well as those requiring integrated analytical and toxicology services.